|
1
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020:
GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin. 71:209–249.
2021.PubMed/NCBI View Article : Google Scholar
|
|
2
|
van den Beuken-Van Everdingen MH,
Hochstenbach LM, Joosten EA, Tjan-Heijnen VC and Janssen DJ: Update
on prevalence of pain in patients with cancer: Systematic review
and meta-analysis. J Pain Symptom Manage. 51:1070–1090.e9.
2016.PubMed/NCBI View Article : Google Scholar
|
|
3
|
WHO Guidelines for the Pharmacological and
Radiotherapeutic Management of Cancer Pain in Adults and
Adolescents. Geneva: World Health Organization; 2018.
|
|
4
|
Trescot AM, Datta S, Lee M and Hansen H:
Opioid pharmacology. Pain Phys. 11(2 Suppl):S133–S153.
2008.PubMed/NCBI
|
|
5
|
Stein C: New concepts in opioid analgesia.
Expert Opin Investig Drugs. 27:765–775. 2018.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Mccleane G and Smith HS: Opioids for
persistent noncancer pain. Med Clin North Am. 91:177–197.
2007.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Stein C: Opioid receptors. Annu Rev Med.
67:433–451. 2016.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Stein C and Machelska H: Modulation of
peripheral sensory neurons by the immune system: Implications for
pain therapy. Pharmacol Rev. 63:860–881. 2011.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Roeckel LA, Utard V, Reiss D, Mouheiche J,
Maurin H, Robé A, Audouard E, Wood JN, Goumon Y, Simonin F and
Gaveriaux-Ruff C: Morphine-induced hyperalgesia involves mu opioid
receptors and the metabolite morphine-3-glucuronide. Sci Rep.
7(10406)2017.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Dhaliwal A and Gupta M: Physiology, Opioid
Receptor. In: StatPearls [Internet]. Treasure Island (FL):
StatPearls Publishing;2022.
|
|
11
|
Millan MJ: Kappa-opioid receptors and
analgesia. Trends Pharmacol Sci. 11:70–76. 1990.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Farmer AD, Holt CB, Downes TJ, Ruggeri E,
Del Vecchio S and De Giorgio R: Pathophysiology, diagnosis, and
management of opioid-induced constipation. Lancet Gastroenterol
Hepatol. 3:203–212. 2018.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Al-Hasani R and Bruchas MR: Molecular
mechanisms of opioid receptor-dependent signaling and behavior.
Anesthesiology. 115:1363–1381. 2011.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Karahan S, Karagöz H, Erden A, Avcı D and
Esmeray K: Codeine-induced syndrome of inappropriate antidiuretic
hormone: Case report. Balkan Med J. 31:107–109. 2014.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Lötsch J and Geisslinger G:
Morphine-6-glucuronide: An analgesic of the future? Clin
Pharmacokinet. 40:485–499. 2001.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Hasselström J and Säwe J: Morphine
pharmacokinetics and metabolism in humans. Enterohepatic cycling
and relative contribution of metabolites to active opioid
concentrations. Clin Pharmacokinet. 24:344–354. 1993.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Smith MT: Neuroexcitatory effects of
morphine and hydromorphone: Evidence implicating the 3-glucuronide
metabolites. Clin Exp Pharmacol Physiol. 27:524–528.
2000.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Kubica J, Kubica A, Jilma B, Adamski P,
Hobl EL, Navarese EP, Siller-Matula JM, Dąbrowska A, Fabiszak T,
Koziński M and Gurbel PA: Impact of morphine on antiplatelet
effects of oral P2Y12 receptor inhibitors. Int J Cardiol.
215:201–208. 2016.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Fine A and Churchill DN: Potentially
lethal interaction of cimetidine and morphine. Can Med Assoc J.
124:1434–1436. 1981.PubMed/NCBI
|
|
20
|
Mojaverian P, Fedder IL, Vlasses PH,
Rotmensch HH, Rocci ML Jr, Swanson BN and Ferguson RK: Cimetidine
does not alter morphine disposition in man. Br J Clin Pharmacol.
14:809–813. 1982.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Shirooie S, Sahebgharani M, Esmaeili J and
Dehpour AR: In vitro evaluation of effects of metformin on morphine
and methadone tolerance through mammalian target of rapamycin
signaling pathway. J Cell Physiol. 234:3058–3066. 2019.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Okura T, Morita Y, Ito Y, Kagawa Y and
Yamada S: Effects of quinidine on antinociception and
pharmacokinetics of morphine in rats. J Pharm Pharmacol.
61:593–597. 2009.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Miyazaki M, Kawase T, Nishimura C,
Kitamura T, Iwanaga K and Kakemi M: Pharmacokinetics and toxicity
of repeated oral etoposide is altered by morphine coadministration
in rats. Eur J Drug Metab Pharmacokinet. 40:335–341.
2015.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Manara AR, Shelly MP, Quinn K and Park GR:
The effect of metoclopramide on the absorption of oral controlled
release morphine. Br J Clin Pharmacol. 25:518–521. 1988.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Rocci ML Jr, Mojaverian P and Saccar CL:
Morphine inhibition of theophylline clearance. Pharm Res.
1:231–233. 1984.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Lopez F, Miller LG, Thompson ML, Schatzki
A, Chesley S, Greenblatt DJ and Shader RI: Chronic morphine
administration augments benzodiazepine binding and GABAA receptor
function. Psychopharmacol (Berl). 101:545–549. 1990.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Kienitz R, Kay L, Beuchat I, Gelhard S,
von Brauchitsch S, Mann C, Lucaciu A, Schäfer JH, Siebenbrodt K,
Zöllner JP, et al: Benzodiazepines in the management of seizures
and status epilepticus: A review of routes of delivery,
pharmacokinetics, efficacy, and tolerability. CNS Drugs.
36:951–975. 2022.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Mancinelli A, Guiso G, Garattini S, Urso R
and Caccia S: Kinetic and pharmacological studies on estazolam in
mice and man. Xenobiotica. 15:257–265. 1985.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Pierce MW and Shu VS: Efficacy of
estazolam. The United States clinical experience. Am J Med.
88(3A):6S–11S. 1990.PubMed/NCBI View Article : Google Scholar
|
|
30
|
France CP, Ahern GP, Averick S, Disney A,
Enright HA, Esmaeli-Azad B, Federico A, Gerak LR, Husbands SM,
Kolber B, et al: Countermeasures for preventing and treating opioid
overdose. Clin Pharmacol Ther. 109:578–590. 2021.PubMed/NCBI View
Article : Google Scholar
|
